title: Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway.
abstract: The cJun N-terminal kinase (JNK)-signaling pathway is activated in response to a variety of stimuli, including environmental insults, and has been implicated in neuronal apoptosis. In this study, we investigated the role that the JNK pathway plays in neurotoxicity caused by thimerosal, an ethylmercury-containing preservative. SK-N-SH cells treated with thimerosal (0-10 microM) showed an increase in the phosphorylated (active) form of JNK and cJun with 5 and 10 microM thimerosal treatment at 2 and 4 h. To examine activator protein-1 (AP-1) transcription, cells were transfected with a pGL2 vector containing four AP-1 consensus sequences and then treated with thimerosal (0-2.5 microM) for 24 h. Luciferase studies showed an increase in AP-1 transcriptional activity upon thimerosal administration. To determine the components of the AP-1 complex, cells were transfected with a dominant negative to either cFos (A-Fos) or cJun (TAM67). Reporter analysis showed that TAM67, but not A-Fos, decreased AP-1 transcriptional activity, indicating a role for cJun in this pathway. To assess which components are essential to apoptosis, cells were treated with a cell-permeable JNK inhibitor II (SP600125) or transfected with TAM67, and the downstream effectors of apoptosis were analyzed. Cells pretreated with SP600125 showed decreases in activation of caspases 9 and 3, decreases in degradation of poly(ADP-ribose) polymerase (PARP), and decreased levels of proapoptotic Bim, in comparison to cells treated with thimerosal alone. However, cells transfected with TAM67 showed no changes in those same components. Taken together, these results indicate that thimerosal-induced neurotoxicity occurs through the JNK-signaling pathway, independent of cJun activation, leading ultimately to apoptotic cell death.
authors.affiliation: Department of Pharmacology, Joan C. Edwards School of Medicine, Marshall University, 1542 Spring Valley Drive, Huntington, WV 25704, USA.
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Herdman
authors.forename: Aileen
authors.initials: A
authors.lastname: Marcelo
authors.forename: Ying
authors.initials: Y
authors.lastname: Huang
authors.forename: Richard M
authors.initials: RM
authors.lastname: Niles
authors.forename: Sanjit
authors.initials: S
authors.lastname: Dhar
authors.forename: Kinsley Kelley
authors.initials: KK
authors.lastname: Kiningham
mesh_terms: D000873:Anthracenes / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009447:Neuroblastoma / Q000201:enzymology / Q000473:pathology*; D010766:Phosphorylation; D013849:Thimerosal / Q000633:toxicity*; D018808:Transcription Factor AP-1 / Q000378:metabolism
chemical_list: D000873:Anthracenes; D004791:Enzyme Inhibitors; D018808:Transcription Factor AP-1; C432165:pyrazolanthrone; D013849:Thimerosal; D048031:JNK Mitogen-Activated Protein Kinases